A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Recruiting

Phase 2

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Sponsor:

Carmot Therapeutics, Inc.

Code:

NCT06628362

Conditions

Overweight or Obese

Type 2 Diabetes Mellitus (T2DM)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

CT-388

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Carmot Therapeutics, Inc. on 2025-04-17.